Is the Pharmaceutical Revolution Paying Off?

National Pharmaceutical Council

Tuesday, January 29, 2002 | 11:00 a.m. – 2:00 p.m.

National Press Club - Ballroom 529 14th Street, NW - 13th Floor

About This Event

Over the past several years, questions about the value and appropriate use of pharmaceuticals have intensified nationwide. Are they worth it? Can we afford them? Federal and state policymakers need better insight on these issues as they consider ways to expand access to prescription drugs. So do employers, insurers, consumers, and health care providers who are weighing the costs and benefits of pharmaceuticals.

Discussion topics will include the effects of pharmaceutical expenditures on longevity and morbidity, as well as on depression treatment costs, and the effect of newer drugs on medical outcomes.

Please join us to learn more about recent research on the costs and benefits of pharmaceutical innovation and to discuss the economic impact these prescription drugs are having on our health care system. During lunch, an expert on pharmaceutical research will discuss the revolution in science and medicine, particularly in genomics.

Agenda

9:30 a.m.	Registration
10:00	Opening Remarks:	Robert B. Helms, AEI
		Karen Williams, NPC
10:10	Changes Over Time in the Costs of Treating Depression
	Presentation:	Ernst R. Berndt, Massachusetts Institute of Technology
	The Relationship between Pharmaceutical Consumption and Mortality and Morbidity in OECD Countries
	Presentation:	H. E. Frech III, University of California at Santa Barbara
	The Contribution of New Drugs to Health and Economic Growth in the United States
	Presentation:	Frank R. Lichtenberg, Columbia University
	The Value of Pharmaceutical Innovation
	Presentation:	Jack A. Meyer, Economic and Social Research Institute
	Moderator:	John E. Calfee, AEI
Noon	Luncheon
12:35 p.m.	Selected Novel Therapeutic Approaches for the Next Decade
	Speaker:	Graham Molineux, Amgen
1:00	Adjournment

National Pharmaceutical Council

Speaker Biographies

Also Visit

What's new on AEI

	The Pentagon’s illusion of choice: Hagel’s 2 options are really 1
	Wild about Larry
	Primary care as affordable luxury
	Solving the chicken-or-egg job problem

AEI Participants

John E.
Calfee

Economist John E. Calfee (1941-2011) studied the pharmaceutical industry and the Food and Drug Administration (FDA), along with the economics of tobacco, tort liability, and patents. He previously worked at the Federal Trade Commission's Bureau of Economics. He had also taught marketing and consumer behavior at the business schools of the University of Maryland at College Park and Boston University. While Mr. Calfee's writings are mostly on pharmaceutical markets and FDA regulation, his academic articles and opinion pieces covered a variety of topics, from patent law and tort liability to advertising and consumer information. His books include Prices, Markets, and the Pharmaceutical Revolution (AEI Press, 2000) and Biotechnology and the Patent System (AEI Press, 2007). Mr. Calfee wrote regularly for AEI's Health Policy Outlook series. He testified before Congress and federal agencies on various topics, including alcohol advertising; biodefense vaccine research; international drug prices; and FDA oversight of drug safety.

H.E.
Frech

Phone: 8058932124
Email: frech@econ.ucsb.edu

Robert B.
Helms

Robert B. Helms has served as a member of the Medicaid Commission as well as assistant secretary for planning and evaluation and deputy assistant secretary for health policy at the U.S. Department of Health and Human Services (HHS). An economist by training, he has written and lectured extensively on health policy and health economics, including the history of Medicare, the tax treatment of health insurance, and compared international health systems. He currently participates in the Health Policy Consensus Group, an informal task force that is developing consumer-driven health reforms. He is the author or editor of several AEI books on health policy, including Medicare in the Twenty-First Century: Seeking Fair and Efficient Reform and Competitive Strategies in the Pharmaceutical Industry.
Phone: 2028625877
Email: rhelms@aei.org
Assistant Info
Name: Catherine Griffin
Phone: 2028625920
Email: catherine.griffin@aei.org